International Immune Tolerance Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Charles Hay, MD
Manchester Royal Infirmary
Principal Investigator - Donna M DiMichele, MD
Weill Cornell Medical College-NY Presybetrian Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
39 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama Birmingham Medical Center
Birmingham, Alabama, United States
- City of Hope Medical Center
Duarte, California, United States
- Children'S Hospital of Orange County
Orange, California, United States
- Mountain States Regional Hemophilia and Thrombosis Center
Aurora, Colorado, United States
- All Children'S Hospital
St. Petersburg, Florida, United States
- Children'S Healthcare of Atlanta
Atlanta, Georgia, United States
- Children'S Memorial Hospital
Chicago, Illinois, United States
- Rush Presbyterian St. Lukes
Chicago, Illinois, United States
- Comprehensive Bleeding Disorders Center
Peoria, Illinois, United States
- Indiana Hemophilia & Thrombosis Center
Indianapolis, Indiana, United States
- Tulane University Hospital and Clinic
New Orleans, Louisiana, United States
- Maine Children'S Cancer Program
Scarborough, Maine, United States
- Children'S Hospital Boston
Boston, Massachusetts, United States
- Tufts - New England Medical Center
Boston, Massachusetts, United States
- University of Michigan Health Hospitals
Ann Arbor, Michigan, United States
- Msu Centers for Bleeding & Clotting Disorders
East Lansing, Michigan, United States
- Children'S Hospital Minneapolis
Minneapolis, Minnesota, United States
- Mayo Comprehensive Hemophilia Center
Rochester, Minnesota, United States
- Kansas City Regional Hemophilia Center-the Children'S Mercy Hospital
Kansas City, Missouri, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Newark Beth Israel Medical Center
Newark, New Jersey, United States
- Saint Michael'S Medical Center
Newark, New Jersey, United States
- Ted R. Montoya Hemophilia Treatment Center
Albuquerque, New Mexico, United States
- Mount Sinai Medical Center
New York, New York, United States
- Ny Presbyterian Hospital
New York, New York, United States
- University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
- Children'S Hospital Medical Center of Akron
Akron, Ohio, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Columbus Children'S Hospital
Columbus, Ohio, United States
- Oregon Health and Science University
Portland, Oregon, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- St. Christopher'S Hospital for Children, Section of Hem/onc
Philadelphia, Pennsylvania, United States
- the Hemophilia Center of Western Pennsylvania
Pittsburgh, Pennsylvania, United States
- St. Jude Children'S Research Hospital
Memphis, Tennessee, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- University of Texas Health Science Center-Gulf States Hemophilia & Thrombosis Center
Houston, Texas, United States
- Children'S Hospital of the King'S Daughters
Norfolk, Virginia, United States
- Naval Medical Center
Portsmouth, Virginia, United States
- Comprehensive Center for Bleeding Disorders
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2002
- Primary completion
- 31 Dec 2010
- Completion
- 31 Dec 2012
- Last update posted
- 7 Dec 2009
- Registered enrollment
- 134
- Registry id
- NCT00212472
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.